Contemporary Management of HIV 2021

Frontiers in HIV Prevention 2021

Tuesday, December 14, 2021
Webinar -- 12:00 PM ET


Specific meetings can focus on any of the following aspects of the management of ART:

  • Individualizing First-line ART
  • Modifying ART in Virologically Suppressed Patients
  • Emerging Paradigms in ART
  • ART Strategies for Heavily Treatment–Experienced Patients
  • Frontiers in HIV Prevention
  • Integrating New Data From CROI 2021
  • Integrating New Data From IAS 2021

The timing and agenda for each individual meeting is as follows:

  • Welcome, CME information, and baseline outcomes questions (10 mins)
  • Case 1 discussion followed by didactic slides (10-15 mins)
  • Case 2 discussion followed by didactic slides (10-15 mins)
  • Case 3 discussion followed by didactic slides (10-15 mins)
  • Question and answer session, concluding outcomes questions (15-20 mins)


David Hardy, MD

Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Senior Director of Evidence-Based Practices
Whitman-Walker Health
Washington, DC

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for patients at risk of HIV infection through the appropriate use of HIV prevention strategies.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for persons at risk of HIV infection.

Learning Objectives

  • Appropriately counsel persons at risk of HIV infection on the optimal use of approved agents for PrEP
  • Incorporate the latest data and expert insights on emerging prevention paradigms into the individualized care of persons at risk of HIV infection
  • Describe the mechanisms of action, efficacy, and safety of investigational PrEP agents in advanced stages of clinical development


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-022-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.